Compare Salesforce, Inc. with Similar Stocks
Dashboard
Company has a low Debt to Equity ratio (avg) at times
Healthy long term growth as Net Sales has grown by an annual rate of 15.31% and Operating profit at 139.21%
The company has declared Positive results for the last 9 consecutive quarters
With ROE of 11.29%, it has a expensive valuation with a 4.33 Price to Book Value
High Institutional Holdings at 85.96%
Stock DNA
Software Products
USD 173,495 Million (Large Cap)
34.00
NA
0.92%
-0.04
12.56%
2.89
Total Returns (Price + Dividend) 
Salesforce, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Salesforce, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Salesforce, Inc. has recently revised its evaluation amid fluctuating market conditions, with its stock priced at $230.54. Over the past year, it has seen significant volatility, with a 52-week high of $369.00 and a low of $221.96, while facing challenges compared to the S&P 500.
Read full news article Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Oct 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 283 Schemes (32.24%)
Held by 801 Foreign Institutions (20.9%)
Quarterly Results Snapshot (Consolidated) - Oct'25 - YoY
YoY Growth in quarter ended Oct 2025 is 8.63% vs 8.30% in Oct 2024
YoY Growth in quarter ended Oct 2025 is 36.61% vs 24.75% in Oct 2024
Annual Results Snapshot (Consolidated) - Jan'25
YoY Growth in year ended Jan 2025 is 8.72% vs 11.18% in Jan 2024
YoY Growth in year ended Jan 2025 is 49.83% vs 1,888.46% in Jan 2024






